🔎 Trials Near Me

Domov › Akutna mieločna levkemija › Missouri › St. Louis

Klinične študije za Akutna mieločna levkemija v St. Louis, MO

22 študij za Akutna mieločna levkemija išče udeležence na lokacijah v St. Louis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Vključevanje udeležencevFaza 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Missouri Baptist Medical Center, St Louis
  • in še 3
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • Mercy Infusion Center - Chippewa, St Louis
  • Mercy Hospital South, St Louis
  • Missouri Baptist Medical Center, St Louis
  • in še 4
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Vključevanje udeležencevFaza 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • in še 2
Starost 18–59 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3
  • Washington University in St Louis, St Louis
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06852222

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • in še 2
Starost 18–59 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Vključevanje udeležencevFaza 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • in še 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Vključevanje udeležencevFaza 3
  • Washington University School of Medicine, St Louis
  • Mercy Hospital Saint Louis, St Louis
6 Months – 21 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Vključevanje udeležencevFaza 1/2
  • Washington University in St. Louis School of Medicine, St Louis
30 Days · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT04065399

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Vključevanje udeležencevOpazovalna študija
  • Washington University in St. Louis, St Louis
Starost 0 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07154823

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3
  • US-St Louis MO-WASHU, St Louis
Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07223814

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Vključevanje udeležencevFaza 1
  • Washington University in St Louis, St Louis
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT06533761

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Vključevanje udeležencevFaza 1/2
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University School of Medicine, St Louis
  • Mercy Hospital Saint Louis, St Louis
Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

Vključevanje udeležencevFaza 1/2
  • Washington University School of Medicine, St Louis
Starost 18 in več · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT06158828

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3
  • Washington University School of Medicine in St. Louis, St Louis
29 Days – 21 Years · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Vključevanje udeležencevFaza 1
  • Washington University School of Medicine, St Louis
Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT06001788

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Vključevanje udeležencevFaza 2
  • Washington University, St Louis
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06529731

Motixafortide for MRD Sensitization in AML

Vključevanje udeležencevFaza 2
  • Washington University School of Medicine, St Louis
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT07392970

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Vključevanje udeležencevOpazovalna študija
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University St. Louis, St Louis
  • Washington University/St. Louis Children's Hospital, St Louis
Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Vključevanje udeležencevFaza 1
  • Washington University in St. Louis, St Louis
Starost 12 in več · Vsi spoli · Posodobljeno 16. mar. 2026 · NCT06994676

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • Washington University School of Medicine, St Louis
Starost 18 in več · Vsi spoli · Posodobljeno 16. okt. 2025 · NCT04986657

Študije za Akutna mieločna levkemija v drugih mestih

Druge študije v St. Louis

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.